VAPO — Vapotherm Share Price
- $13.49m
- $128.99m
- $68.67m
- 36
- 72
- 68
- 59
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.19 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | -42.51% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 48.1 | 125.73 | 113.29 | 66.8 | 68.67 | 83 | 100.5 | 10.14% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology. It develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. It is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.
Directors
- James Liken NEC (71)
- Joseph Army PRE (57)
- John Landry CFO (48)
- Brian Lawrence SVP (52)
- Gregoire Ramade SVP (51)
- Dorota Mckay CAO (39)
- Lori Knowles DRC
- Mary Moynihan DRC
- Anthony Arnerich IND (71)
- Lance Berry IND (48)
- Donald Spence IND (67)
- Elizabeth Weatherman IND (61)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- March 12th, 2013
- Public Since
- November 14th, 2018
- No. of Shareholders
- 168
- No. of Employees
- 182
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 6,244,935

- Address
- 100 Domain Drive, EXETER, 03833
- Web
- https://vapotherm.com/
- Phone
- +1 6036580411
- Auditors
- Grant Thornton LLP
Upcoming Events for VAPO
Vapotherm Inc Annual Shareholders Meeting
Q3 2024 Vapotherm Inc Earnings Release
Q4 2024 Vapotherm Inc Earnings Release
Similar to VAPO
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
As of Today at 24:25 UTC, shares in Vapotherm are trading at $2.16. This share price information is delayed by 15 minutes.
Shares in Vapotherm last closed at $2.16 and the price had moved by -35.71% over the past 365 days. In terms of relative price strength the Vapotherm share price has underperformed the S&P500 Index by -46.28% over the past year.
The overall consensus recommendation for Vapotherm is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreVapotherm does not currently pay a dividend.
Vapotherm does not currently pay a dividend.
Vapotherm does not currently pay a dividend.
To buy shares in Vapotherm you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $2.16, shares in Vapotherm had a market capitalisation of $13.49m.
Here are the trading details for Vapotherm:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: VAPO
Based on an overall assessment of its quality, value and momentum Vapotherm is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Vapotherm is $1.00. That is 53.7% below the last closing price of $2.16.
Analysts covering Vapotherm currently have a consensus Earnings Per Share (EPS) forecast of -$2.88 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vapotherm. Over the past six months, its share price has outperformed the S&P500 Index by +50.7%.
As of the last closing price of $2.16, shares in Vapotherm were trading +40.51% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Vapotherm PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.16.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Vapotherm's management team is headed by:
- James Liken - NEC
- Joseph Army - PRE
- John Landry - CFO
- Brian Lawrence - SVP
- Gregoire Ramade - SVP
- Dorota Mckay - CAO
- Lori Knowles - DRC
- Mary Moynihan - DRC
- Anthony Arnerich - IND
- Lance Berry - IND
- Donald Spence - IND
- Elizabeth Weatherman - IND